RELIEF THERAPEUTICS Holding SA

RELIEF THERAPEUTICS Holding SA is a Swiss biopharmaceutical company based in Geneva, specializing in the development and commercialization of innovative therapies for rare metaboli

c, dermatological, and pulmonary diseases. Founded in 2013, the company is listed on the SIX Swiss Exchange and the U.S. OTCQB. The company aims to improve the quality of life for patients with chronic rare conditions by enhancing the efficacy, safety, and convenience of treatments. Relief Therapeutics focuses on three main areas: rare metabolic disorders, rare dermatological conditions, and rare pulmonary diseases. Its portfolio includes both commercial products, such as SETOFILM and OLPRUVA, and a clinical pipeline with candidates like RLF-100 for Acute Respiratory Distress Syndrome and RLF-TD011 for Epidermolysis Bullosa. Recently, Relief Therapeutics announced a merger with NeuroX Group SA to form MindMaze Therapeutics, which will expand its focus into digital neurotherapeutics and brain health.